Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Human PINK1 ELISA Kit (AC2436)
Cat.#: ASET-1025
Specifications
Description Human PINK1 ELISA Kit allows for the in vitro quantitative determination of human PINK1 concentrations in serum, plasma, tissue homogenates, and other biological fluids. The kit employs the sandwich enzyme immunoassay technique. Size 96T Sample Type Serum, plasma, tissue homogenates, and other biological fluids. Reactivity Human Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 0.094 ng/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 0.156-10 ng/mL Assay Time 4h 30m Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-1418 Mouse Aromatase ELISA Kit (AC2829) Quantitative inquiry ASET-1521 Porcine eNOS ELISA Kit (AC2932) Quantitative inquiry ASET-1684 Human BMAL1 ELISA Kit (AC3095) Quantitative inquiry ASET-2335 Human Ghrelin ELISA Kit (AC3746) Quantitative inquiry ASET-2008 Human DIO2 ELISA Kit (AC3419) Quantitative inquiry ASET-2502 Human G-Protein Coupled Receptor 30 ELISA Kit (AC3913) Quantitative inquiry ASET-2519 Human Laminin beta 2 ELISA Kit (AC3930) Quantitative inquiry ASET-1525 Human beta Catenin ELISA Kit (AC2936) Quantitative inquiry ASET-1232 Human NENF ELISA Kit (AC2643) Quantitative inquiry ASET-1316 Mouse Nenf ELISA Kit (AC2727) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket